JPH0651616B2 - Salts of oxoproline with piperidinodiaminopyrimidine oxide, and compositions containing the same - Google Patents

Salts of oxoproline with piperidinodiaminopyrimidine oxide, and compositions containing the same

Info

Publication number
JPH0651616B2
JPH0651616B2 JP61116286A JP11628686A JPH0651616B2 JP H0651616 B2 JPH0651616 B2 JP H0651616B2 JP 61116286 A JP61116286 A JP 61116286A JP 11628686 A JP11628686 A JP 11628686A JP H0651616 B2 JPH0651616 B2 JP H0651616B2
Authority
JP
Japan
Prior art keywords
oxoproline
formula
oxide
salt
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP61116286A
Other languages
Japanese (ja)
Other versions
JPS6269A (en
Inventor
ジー.ディ スキエナ ミケレ
オッルー ビットリア
Original Assignee
ホワイトホール・イタリア・ソシエタ・ペル・アチオニ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ホワイトホール・イタリア・ソシエタ・ペル・アチオニ filed Critical ホワイトホール・イタリア・ソシエタ・ペル・アチオニ
Publication of JPS6269A publication Critical patent/JPS6269A/en
Publication of JPH0651616B2 publication Critical patent/JPH0651616B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4913Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having five membered rings, e.g. pyrrolidone carboxylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/494Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom
    • A61K8/4953Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with more than one nitrogen as the only hetero atom containing pyrimidine ring derivatives, e.g. minoxidil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24Oxygen or sulfur atoms
    • C07D207/262-Pyrrolidones
    • C07D207/2732-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
    • C07D207/277Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D207/282-Pyrrolidone-5- carboxylic acids; Functional derivatives thereof, e.g. esters, nitriles

Description

【発明の詳細な説明】 本発明は、毛髪欠乏あるいは脱毛症もしくは剥離性皮膚
炎等の病理的な形状における治療用の医薬および化粧料
の分野において有用な、式(I): で示される5-オキソプロリンと6-ピペリジノ-2,4-ジア
ミノピリミジン-3-オキシドとの塩に関する。また、式
(I)の化合物を包含する局所用製剤にも関する。
DETAILED DESCRIPTION OF THE INVENTION The present invention has the formula (I): useful in the field of pharmaceuticals and cosmetics for the treatment of pathological forms such as hair deficiency or alopecia or exfoliative dermatitis. And a salt of 5-oxoproline with 6-piperidino-2,4-diaminopyrimidine-3-oxide. Also, the formula
It also relates to a topical formulation comprising a compound of (I).

本発明の目的は、式(I): で示される5-オキソプロリンと6-ピペリジノ-2,4-ジア
ミノピリミジン-3-オキシドとの塩を提供することにあ
る。
The object of the present invention is the formula (I): Is to provide a salt of 5-oxoproline and 6-piperidino-2,4-diaminopyrimidine-3-oxide.

式(I)の化合物は頭髪または他の体毛の成長に有利な活
性を付与するので、適当な局所製剤の形で化粧料、医薬
品または獣医学の分野で使用することができる。
Since the compounds of formula (I) impart a beneficial activity on the growth of hair or other body hair, they can be used in the field of cosmetics, pharmaceuticals or veterinary medicine in the form of suitable topical preparations.

本発明の他の目的は、式(I): で示される5-オキソプロリンと6-ピペリジノ-2,4-ジア
ミノピリミジン-3-オキシドとの塩および医薬上許容さ
れる賦形剤からなる、毛髪の成長を刺激するのに使用し
たり、禿頭症を治療するために局所適用される医薬組成
物を提供することにある。
Another object of the invention is the formula (I): A salt of 5-oxoproline and 6-piperidino-2,4-diaminopyrimidine-3-oxide represented by and a pharmaceutically acceptable excipient, which is used for stimulating hair growth or baldness. The purpose of the present invention is to provide a pharmaceutical composition which is applied topically to treat a disease.

本発明のさらに他の目的は、式(I): で示される5-オキソプロリンと6-ピペリジノ-2,4-ジア
ミノピリミジン-3-オキシドとの塩を適当な賦形剤と混
合して含む化粧用組成物を提供することにある。
Yet another object of the invention is the formula (I): The present invention provides a cosmetic composition containing the salt of 5-oxoproline and 6-piperidino-2,4-diaminopyrimidine-3-oxide represented by the formula (1) in admixture with a suitable excipient.

式(I)の塩の基本成分を構成する-2,4-ジアミノピリミジ
ン誘導体は、国際的な非独占的名称であるミノキシジル
(Minoxidil)として公知である。この化合物は現在、抗
高血圧薬としてヒトの治療に使用されており、最近は通
常のハゲおよび通気性脱毛症の治療における局所的応用
が報告されている。
The 2,4-diaminopyrimidine derivative, which constitutes the basic constituent of the salt of the formula (I), is the international non-proprietary name minoxidil.
(Minoxidil) is known. This compound is currently used in the treatment of humans as an antihypertensive drug and has recently been reported for topical application in the treatment of normal baldness and alopecia areata.

ミノキシジルは水不溶性であるので、その液体製剤はグ
リコールおよびポリアルコール系であり、従って、頭皮
を油性にする傾向があるので局所的使用は望ましくな
い。
Since minoxidil is water-insoluble, its liquid formulation is glycol and polyalcohol based and thus tends to make the scalp oily, thus making topical use undesirable.

それとは異なり、本発明による前記の塩は水溶性であ
り、水系組成物中に容易に配合することができる。
On the contrary, the salts according to the invention are water-soluble and can be easily incorporated into aqueous compositions.

式(I)の塩の酸化合物であるL-5-オキソプロリンは、ピ
ログルタミン酸(PGA)としても知られており、自然な湿
気を与える成分として化粧料−皮膚学の分野で既に使用
されている。その化合物は積極的に作用して頭髪および
頭皮の水分補給の最適状態を維持し、それらの病理的な
変調を防止しおよび治療する。
L-5-oxoproline, an acid compound of the salt of formula (I), also known as pyroglutamic acid (PGA), has already been used in the field of cosmetics-dermatology as a natural moisturizing component. There is. The compounds act positively to maintain optimal hydration of the hair and scalp, prevent and treat their pathological alterations.

本発明者は本発明の目的である新規の塩(以下、「MT/
1」と称することがある)が、頭髪および体毛の欠損の
防止および治療に特に適した性質をもつものであること
を見出した。新規の化合物は、ミノキシジル単独と比較
実験をした場合に、毛髪欠損の防止および治療に優れて
いることが分かった。事実、MT/1はミノキシジル単独
よりも、一層容易に吸着させることができることが分か
った。
The present inventor has developed a novel salt (hereinafter referred to as “MT /
1)) has properties particularly suitable for the prevention and treatment of hair and body hair defects. The novel compound was found to be excellent in preventing and treating hair loss when compared with minoxidil alone. In fact, it has been found that MT / 1 can be adsorbed more easily than minoxidil alone.

本発明の目的である新規化合物は更に、水に易溶性であ
り、この性質のため、完全にまたは大部分が水系の特に
トリコロジー分野に適した処方に使用するのに適してい
る。
The novel compounds which are the object of the present invention are furthermore readily soluble in water and, due to this property, are suitable for use in formulations which are wholly or largely water-based, especially suitable for the field of trilogy.

MT/1の全身性毒性および皮膚耐性は、局所投与の場合
に、ミノキシジル単独での公知の値の範囲内にある。従
って、式(I)の化合物は、好ましくは完全にまたは大部
分が水系のローション、クリーム、スプレー、シャンプ
ー、ゲル、ヘアオイル(ブリリアンティン)および頭髪
固定剤に有利に処方することができる。
The systemic toxicity and skin tolerance of MT / 1 are within the range of known values for minoxidil alone when administered topically. Thus, the compounds of formula (I) can be advantageously formulated in preferably wholly or predominantly aqueous lotions, creams, sprays, shampoos, gels, hair oils (brilliantine) and hair fixatives.

本発明の目的である組成物は、式(I)の化合物の他に、
相補的な活性をもつ他の活性成分、更には通常使用する
賦形剤例えば芳香剤、安定剤、染料等を含有することが
できる。
The composition which is the object of the present invention comprises, in addition to the compound of formula (I),
Other active ingredients with complementary activities can be included as well as the customary excipients such as fragrances, stabilizers, dyes and the like.

本発明の組成物は活性成分を0.1〜10%の濃度で含み、
治療すべき領域に一般には1日1回または2回塗布す
る。なお、通常の使用量では、重篤な副作用は見られな
い。
The composition of the invention comprises the active ingredient in a concentration of 0.1-10%,
The area to be treated is generally applied once or twice a day. No serious side effects were observed at the usual doses.

新規化合物の調製は当業界で公知の技術を使用して行な
う。例えば、実用上化学量論的量でミノキシジルとL−
5−オキソプロリンとを反応させることにより、水中で
簡単に調製することができる。本発明の化合物は他の適
当な溶媒例えばメタノール、エタノール、イソプロパノ
ール等を使用して無水または部分水和物の形で容易に調
製することができる。
The preparation of the new compounds is done using techniques known in the art. For example, practically stoichiometric amounts of minoxidil and L-
It can be easily prepared in water by reacting with 5-oxoproline. The compounds of the present invention can be readily prepared in anhydrous or partially hydrated form using other suitable solvents such as methanol, ethanol, isopropanol and the like.

式(I)の化合物は通常の技術例えば溶媒蒸発または非溶
媒による沈殿等によって単離する。
The compound of formula (I) is isolated by conventional techniques such as solvent evaporation or precipitation with a non-solvent.

以下、実施例によって本発明を具体的に説明するが、こ
れは本発明を限定するものではない。
Hereinafter, the present invention will be described in detail with reference to Examples, but the present invention is not limited thereto.

例1 水50ml中のミノキシジル2gの懸濁液中に、L−オキソプ
ロリン1.3gを加えた。得られた溶液は、局所適用に適し
た調製物としてそのまま使用することのできるものであ
る。あるいは、化合物を、例えば好ましくは低圧下で水
を蒸発させることによって固体の形で単離することがで
きる。こうして得られた式(I)の化合物を化学的に試験
したところ、そのIRスペクトルから完全に純粋であるこ
とがわかった。
Example 1 1.3 g of L-oxoproline was added to a suspension of 2 g of minoxidil in 50 ml of water. The resulting solution is ready for use as a preparation suitable for topical application. Alternatively, the compound can be isolated in solid form, for example by evaporating the water, preferably under low pressure. The compound of formula (I) thus obtained was chemically tested and found to be completely pure by its IR spectrum.

例2 ミノキシジル2.09gとL−オキソプロリン1.29gとを95%
エタノール100ml中に溶解した。得られた溶液はそのま
ま使用するかまたは適当に希釈することができ、そして
(または)コアジュバントもしくは相補物質を加えるこ
とができる。
Example 2 95% of minoxidil 2.09 g and L-oxoproline 1.29 g
It was dissolved in 100 ml of ethanol. The resulting solution can be used as is or diluted appropriately and / or co-adjuvants or complementary substances can be added.

あるいは、溶媒を完全に蒸発させるかまたは部分的に蒸
発させてエチルエーテルを不溶化剤として続けて加える
ことにより、固体化合物を単離することができる。得ら
れた固体化合物は例1で得られた化合物と化学的に一致
した。
Alternatively, the solid compound can be isolated by complete evaporation or partial evaporation of the solvent and subsequent addition of ethyl ether as an insolubilizing agent. The solid compound obtained was chemically consistent with the compound obtained in Example 1.

例3 処方例 前記例1または例2によって調製した塩の処方の組成を
以下に説明する。
Example 3 Formulation Example The composition of the salt formulation prepared according to Example 1 or Example 2 above is described below.

(a)ローション MT/1 3.38g アスコルビン酸ナトリウム 0.5g 保存剤 適量 加香着色水 100gにする量 (b)ローション MT/1 3.38g ビタミンH 1g イノサイト(Inosite)(R) 1g パントテン酸カルシウム 1g アミノ酸複合体 0.2g ビタミンB複合体 5g イソプロピルアルコール 520g 加香水 1000gにする量 (c)ローション MT/1 3.38g ウコン(Ucon)(R)75-H-450 10g バンサイド(Vancide)(R)89 RE 0.1g フラグランス(Fragrance) 適量 エチルアルコール(95度) 50g 水 100gにする量 (d)エーロゾルローション MT/1 3.38g パンテノール 1g ラノゲル(Lanogel)21(R) 0.5g ゼレック(Zelek)MK(R)(帯電防止剤) 0.1g フラグランス(Fragrance) 適量 アルコール 25g フレオン(Freon)(R)11/12(60:40) 70g (e)ローション MT/1 3.38g アルコール 30g フラグランス(Fragrance) 痕跡量 着色剤 適量 水 100gにする量 (f)ローション MT/1 3.38g レゾルシン 5g カプシカム(capsicum)のチンキ 5g レシン油 5g アルコール(90度) 100gにする量 フラグランス(Fragrance) 適量 (g)ローション MT/1 3.38g β−ナフトール 0.5g グリセリン 5g アルコール(90度) 50g フラグランス(Fragrance) 適量 水 100gにする量 (h)ローション MT/1 3.38g イソプロピルアルコール 50g フラグランス(Fragrance) 適量 サリチル酸 0.2g 水 100gにする量 (i)エーロゾルフォームローション MT/1 3.38g セチルアルコール 0.8g サポゲート(Sapogenat)T/100(R) 0.2g ネオ−エクストラポン(Neo-ExtraponH(R) 2g イソ−アジパート(Iso-Adipat)(R) 1g 水溶性Neo-PSL(R) 2g メントール 0.2g エマルゾゲン(Emulsogen)OG(R) 2g ホスタファト(Hostaphat)KL.340(R) 2.5g エチルアルコール 45g フラグランス(Fragrance) 1.2g 水 100gにする量 上記成分を 85gに充填する 噴射剤:12/114(10:60) 15g (j)クリーム MT/1 3.38g ステアリン酸ジグリコール 12g ステアリン酸トリエタノールアミン 5g ラノリン 4g コレステリン 5g レシチン 0.5g セバシン酸ジエチル 0.5g ミリスチン酸イソプロピル 10g 保存剤 適量 水 63g (k)シャンプー MT/1 3.38g サッカロースモノラウレット 50g フラグランス(Fragrance)または着色剤 適量 水 100gにする量 (l)頭髪固定剤 MT/1 3.84g アルギン酸ナトリウム 1.2g クエン酸カルシウム 0.1g アルコール 3g フラグランス(Fragrance) 適量 保存剤 適量 水 100gにする量(a) Lotion MT / 1 3.38g Sodium ascorbate 0.5g Preservative Amount to make 100g of perfume coloring water (b) Lotion MT / 1 3.38g Vitamin H 1g Inosite (R) 1g Calcium pantothenate 1g Amino acid complex 0.2 g Vitamin B complex 5 g Isopropyl alcohol 520 g Perfume 1000 g Amount (c) Lotion MT / 1 3.38 g Turmeric (Ucon) (R) 75-H-450 10 g Vancide (R) 89 RE 0.1g Fragrance Appropriate amount Ethyl alcohol (95 ° C) 50g Amount to make water 100g (d) Aerosol lotion MT / 1 3.38g Panthenol 1g Lanogel 21 (R) 0.5g Zelek MK (R) ) (Antistatic agent) 0.1g Fragrance (Fragrance) Appropriate amount of alcohol 25g Freon (R) 11/12 (60:40) 70g (e) Lotion MT / 1 3.38g Alcohol 30g Fragrance Trace amount Colorant Appropriate amount of water 100 g (f) MT / 1.38g Resorcin 5g Capsicum tincture 5g Resin oil 5g Alcohol (90 degrees) 100g Amount Fragrance (g) Lotion MT / 1 3.38g β-naphthol 0.5g Glycerin 5g Alcohol (90 degree) 50g Fragrance (Fragrance) Appropriate amount of water 100g (h) Lotion MT / 1.38g Isopropyl alcohol 50g Fragrance (Fragrance) Appropriate amount of salicylic acid 0.2g Water 100g (i) Aerosol foam lotion MT / 1 3.38g Cetyl alcohol 0.8g Sapogenat T / 100 (R) 0.2g Neo-Extrapon H (R) 2g Iso-Adipat (R) 1g Water-soluble Neo-PSL (R) ) 2g Menthol 0.2g Emulsogen OG (R) 2g Hostaphat KL.340 (R) 2.5g Ethyl alcohol 45g Fragrance 1.2g Water 100g Amount of the above ingredients to 85g Filling propellant: 12/114 (10:60) 15g (j) Cream MT / 1 3.38g Diglycol stearate 12g Triethanolamine stearate 5g Lanolin 4g Cholesterin 5g Lecithin 0.5g Diethyl sebacate 0.5g Isopropyl myristate 10g Preservatives Water 63g (k) Shampoo MT / 1 3.38g Sucrose monolauret 50g Fragrance or colorant Water 100g Amount (l) Hair fixative MT / 1 3.84g Sodium alginate 1.2g Quench Calcium acid 0.1g Alcohol 3g Fragrance Suitable amount Preservative Suitable amount Water 100g

Claims (4)

【特許請求の範囲】[Claims] 【請求項1】式(I): で示される5-オキソプロリンと6-ピペリジノ-2,4-ジア
ミノピリミジン-3-オキシドとの塩。
1. Formula (I): A salt of 5-oxoproline with 6-piperidino-2,4-diaminopyrimidine-3-oxide.
【請求項2】式(I): で示される5-オキソプロリンと6-ピペリジノ-2,4-ジア
ミノピリミジン-3-オキシドとの塩および医薬上許容さ
れる賦形剤からなる、毛髪の成長を刺激するのに使用し
たり、禿頭症を治療するために局所適用される医薬組成
物。
2. Formula (I): A salt of 5-oxoproline and 6-piperidino-2,4-diaminopyrimidine-3-oxide represented by and a pharmaceutically acceptable excipient, which is used for stimulating hair growth or baldness. A pharmaceutical composition applied topically to treat a symptom.
【請求項3】式(I): で示される5-オキソプロリンと6-ピペリジノ-2,4-ジア
ミノピリミジン-3-オキシドとの塩を適当な賦形剤と混
合して含む化粧用組成物。
3. Formula (I): A cosmetic composition comprising a salt of 5-oxoproline and 6-piperidino-2,4-diaminopyrimidine-3-oxide represented by the above formula in admixture with a suitable excipient.
【請求項4】ローション、シャンプー、毛髪固定剤、ク
リームまたはスプレーの形態である特許請求の範囲第3
項記載の化粧用組成物。
4. A third claim in the form of a lotion, shampoo, hair fixative, cream or spray.
The cosmetic composition according to the item.
JP61116286A 1985-05-22 1986-05-22 Salts of oxoproline with piperidinodiaminopyrimidine oxide, and compositions containing the same Expired - Lifetime JPH0651616B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT8520836A IT1214610B (en) 1985-05-22 1985-05-22 COMPOUND FOR DERMATOLOGICAL COSMETIC USE AND RELATED COMPOSITIONS.
IT20836A85 1985-05-22

Publications (2)

Publication Number Publication Date
JPS6269A JPS6269A (en) 1987-01-06
JPH0651616B2 true JPH0651616B2 (en) 1994-07-06

Family

ID=11172771

Family Applications (1)

Application Number Title Priority Date Filing Date
JP61116286A Expired - Lifetime JPH0651616B2 (en) 1985-05-22 1986-05-22 Salts of oxoproline with piperidinodiaminopyrimidine oxide, and compositions containing the same

Country Status (7)

Country Link
JP (1) JPH0651616B2 (en)
CH (1) CH667651A5 (en)
DE (1) DE3617124A1 (en)
FR (1) FR2582304B1 (en)
GB (1) GB2175901B (en)
IL (2) IL78842A0 (en)
IT (1) IT1214610B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5300510A (en) * 1988-09-23 1994-04-05 Norchim Salt of 6-piperidino-2,4-diaminopyrimidine 3-oxide and aceturic acid, its preparation and its dermato-cosmetological application
FR2636840B1 (en) * 1988-09-23 1990-12-21 Norchim Sarl SALT OF 6-PIPERIDINO-2,4-DIAMINOPYRIMIDINE-3-OXIDE AND ACETURIC ACID, THEIR PREPARATION AND THEIR DERMATOCOSMETOLOGICAL APPLICATIONS
FR2706896B1 (en) * 1993-06-23 1996-04-12 Caillot Jean Luc

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2188599A5 (en) * 1972-06-12 1974-01-18 Fabre Sa Pierre (Pyro)glutamic acid derivs - from (substd) ethylenediamine, substd guanidine and dimethyl amino ethanol
LU73680A1 (en) * 1975-10-29 1977-05-31
US4139619A (en) * 1976-05-24 1979-02-13 The Upjohn Company 6-Amino-4-(substituted amino)-1,2-dihydro-1-hydroxy-2-iminopyrimidine, topical compositions and process for hair growth
GB2140257B (en) * 1980-12-04 1985-09-18 Quantel Ltd Video image creation
DE3280344D1 (en) * 1981-11-09 1991-07-25 Gail S Bazzano USE OF RETINOIDES AND MINOXIDIL (2,4-DIAMINO-6-PIPERIDINO-PYRIMIDINE-3-OXIDE) TO IMPROVE THE GROWTH OF HUMAN HEAD HAIR AND TO TREAT CERTAIN TYPES OF ALOPECIA.
JPS5888307A (en) * 1981-11-19 1983-05-26 Takeo Kinji Minoxidil-containing hair tonic
JPS5888306A (en) * 1981-11-19 1983-05-26 Takeo Kinji Hair tonic cosmetic
US4452989A (en) * 1982-06-01 1984-06-05 Charles Of The Ritz Group Ltd. Substantive moisturizing derivatives of 2-pyrrolidone-5-carboxylic acid and compositions containing same

Also Published As

Publication number Publication date
IL78842A (en) 1989-09-28
GB2175901A (en) 1986-12-10
IL78842A0 (en) 1986-09-30
GB2175901B (en) 1988-09-21
FR2582304A1 (en) 1986-11-28
IT1214610B (en) 1990-01-18
DE3617124A1 (en) 1986-11-27
CH667651A5 (en) 1988-10-31
GB8612461D0 (en) 1986-07-02
IT8520836A0 (en) 1985-05-22
FR2582304B1 (en) 1989-06-02
DE3617124C2 (en) 1992-07-16
JPS6269A (en) 1987-01-06

Similar Documents

Publication Publication Date Title
JPH0552806B2 (en)
JP4940527B2 (en) Sustainable hair growth composition
US6468552B1 (en) Stabilized compositions containing oxygen-labile active agents
JPH0791278B2 (en) Salt of N-acyl thiazolidinecarboxylic acid and piperidinodiaminopyrimidine oxide, and composition containing the same
US4866067A (en) 6-piperidino-2,4-diaminopyrimidine-3-oxide salt of 3-carboxypyridine n-oxide and topical, related compositions
JP3220761B2 (en) Hair restoration
JPH11139951A (en) Cosmetic
JPH0651616B2 (en) Salts of oxoproline with piperidinodiaminopyrimidine oxide, and compositions containing the same
JP4032246B2 (en) White hair prevention and improvement agent
EP0260697B1 (en) Composition for application to hair
JPH10279437A (en) Hair cosmetic
JPH0386811A (en) Cosmetic article compound
WO2019151275A1 (en) Method for improving stickiness of adenosine-phosphate-containing composition
JPH11302133A (en) Cosmetic for scalp and hair
JPH01287014A (en) Combination of pyrimidine derivative, urea and/or allantoin derivative for inducing and stimulating growth of hair to reduce loss thereof
JP2001131025A (en) Cosmetic for scalp and hair
JPH11302131A (en) Cosmetic for scalp and hair
JPH07206647A (en) Hair tonic
JP2000178140A (en) Hair tonic preparation
JP3516792B2 (en) External preparation for skin
JPH10147514A (en) Cosmetic
JP2814090B2 (en) Hair restoration
JP2002114645A (en) Hair tonic
JP2001122739A (en) Hair tonic
JPH09202724A (en) Skin preparation composition for external use